Fundraising Fox
CHS Healthcare Ventures
Decatur, US · Founded 2016 · Delaware corporation
Find your way into CHS Healthcare Ventures
Sign up to see every warm intro you have to CHS Healthcare Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CHS Healthcare Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lightengale develops an illuminated intravenous tubing (IVT) system that uses a light-emitting fiber optic cable along the tubing to help nurses quickly and accurately identify IV lines, reducing manual line-tracing errors. The device targets ICU settings, including pediatric and neonatal patients, to reduce medication errors and improve efficiency.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$659.8K disclosed across 1 round · 2020
▶$659.8KraisedMay 2020 · 6 investors · Other Health CareRule 506(b)
- HANS UTZExecutive Officer, Director
- Offering amount
- $900K
- Amount sold
- $659.8K
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase ISTTR | 2021 | $256K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2020 | $298.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does CHS Healthcare Ventures do?
- Lightengale develops an illuminated intravenous tubing (IVT) system that uses a light-emitting fiber optic cable along the tubing to help nurses quickly and accurately identify IV lines, reducing manual line-tracing errors. The device targets ICU settings, including pediatric and neonatal patients, to reduce medication errors and improve efficiency.
- How much funding has CHS Healthcare Ventures raised?
- CHS Healthcare Ventures has disclosed $659.8K raised across 1 round.
- Where is CHS Healthcare Ventures headquartered?
- CHS Healthcare Ventures is headquartered in Decatur, US.